METOLAZONE

Post-LOE

metolazone

Teva

ANDAORALTABLET

Approved

Jul 2004

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

5/8 — Partial

METOLAZONE (metolazone) by Teva is clinical pharmacology metolazone is a quinazoline diuretic, with properties generally similar to the thiazide diuretics. Approved for salt, water retention including: edema accompanying congestive heart failure, hypertension and 4 more indications. First approved in 2004.

Drug data last refreshed 20h ago

$0.0BPart D

Mechanism of Action

CLINICAL PHARMACOLOGY Metolazone is a quinazoline diuretic, with properties generally similar to the thiazide diuretics. The actions of metolazone result from interference with the renal tubular mechanism of electrolyte reabsorption. Metolazone acts primarily to inhibit sodium reabsorption at the…

Indications (7)

Worked on METOLAZONE at Teva? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

METOLAZONE

Mechanism of Action

Indications (7)

Clinical Trials (1)